{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:18:44Z","timestamp":1784557124072,"version":"3.55.0"},"reference-count":34,"publisher":"Bioscientifica","issue":"5","content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p>\n                    The proteoglycan neuron-glial antigen 2 (NG2) is expressed by oligodendrocyte progenitors, pericytes, and some cancerous cells where it is implicated in tumor development. We examined mice with NG2-driven pRb inactivation. Unexpectedly,\n                    <jats:italic>NG2-Cre:pRb<\/jats:italic>\n                    <jats:italic>\n                      <jats:sup>flox\/flox<\/jats:sup>\n                    <\/jats:italic>\n                    mice developed pituitary tumors with high penetrance. Adenohypophysial neoplasms developed initially as multifocal lesions; by 1 year, large tumors showed brain invasion. Immunohistochemistry identified these as Pit1-lineage neoplasms, with variable immunoreactivity for growth hormone, prolactin, thyrotropin, and \u03b1-subunit of glycoprotein hormones. Other than modest hyperprolactinemia, circulating hormone levels were not elevated. To determine the role of NG2 in the pituitary, we investigated NG2 expression. Immunoreactivity was identified in anterior and posterior lobes but not in the intermediate lobe of the mouse pituitary; in the adenohypophysis, folliculostellate cells had the strongest NG2 immunoreactivity but showed no proliferation in response to Rb inactivation. Pit1-positive adenohypophysial cells were positive for NG2, but corticotroph and gonadotroph cells were negative. RT-PCR revealed NG2 expression in normal human pituitary and human pituitary tumors; immunohistochemistry localized NG2 in nontumorous human adenohypophysis with strongest positivity in folliculostellate cells, and in tumors of all types except corticotrophs. Functional studies in GH4 mammosomatotrophs showed that NG2 increases prolactin (PRL), reduces growth hormone (GH) expression, and enhances cell adhesion without influencing proliferation. In conclusion, NG2-driven pRb inactivation results in pituitary tumors that mimic endocrinologically inactive Pit1-lineage human pituitary tumors. This model identifies a role for NG2 in pituitary cell-type-specific functions and unmasks a protective role from Rb inactivation in folliculostellate cells; it can be used for further research, including preclinical testing of novel therapies.\n                  <\/jats:p>","DOI":"10.1530\/erc-16-0013","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T23:03:03Z","timestamp":1459897383000},"page":"445-456","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":10,"title":["NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cells"],"prefix":"10.1530","volume":"23","author":[{"given":"Toru","family":"Tateno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae","family":"Nakano-Tateno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2016061019141304000_23.5.445.1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0189"},{"key":"2016061019141304000_23.5.445.2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1750-3639.2001.tb00406.x","article-title":"Transgenic and knockout mouse models clarify pituitary development, function and disease","volume":"11","author":"Asa","year":"2001","journal-title":"Brain Pathology"},{"key":"2016061019141304000_23.5.445.3","unstructured":"Asa SL 2011 Tumors of the pituitary gland. In AFIP Atlas of Tumor Pathology, Series 4, Fascicle 15, Silver Spring, MD, USA: ARP Press."},{"key":"2016061019141304000_23.5.445.4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.4.110807.092259"},{"key":"2016061019141304000_23.5.445.5","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-013-9276-5"},{"key":"2016061019141304000_23.5.445.6","doi-asserted-by":"publisher","DOI":"10.1586\/17446651.2016.1153422"},{"key":"2016061019141304000_23.5.445.7","first-page":"403","article-title":"Structure-function correlations of human pituitary gonadotroph adenomas","volume":"58","author":"Asa","year":"1988","journal-title":"in vitro. Laboratory Investigation"},{"key":"2016061019141304000_23.5.445.8","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350272"},{"key":"2016061019141304000_23.5.445.9","doi-asserted-by":"crossref","unstructured":"Chang Y She ZG Sakimura K Roberts A Kucharova K Rowitch DH Stallcup WB 2012 Ablation of NG2 proteoglycan leads to deficits in brown fat function and to adult onset obesity. PLoS ONE 7 e30637. (doi:10.1371\/journal.pone.0030637)","DOI":"10.1371\/journal.pone.0030637"},{"key":"2016061019141304000_23.5.445.10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.3.1118"},{"key":"2016061019141304000_23.5.445.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1668"},{"key":"2016061019141304000_23.5.445.12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20412"},{"key":"2016061019141304000_23.5.445.13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2009","journal-title":"Clinical Endocrinology"},{"key":"2016061019141304000_23.5.445.14","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.53738\/REVMED.2009.5.223.2172","article-title":"Epidemiology of pituitary adenoma: results of the first Swiss study","volume":"5","author":"Fontana","year":"2009","journal-title":"Revue M\u00e9dicale Suisse"},{"key":"2016061019141304000_23.5.445.15","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.10359"},{"key":"2016061019141304000_23.5.445.16","doi-asserted-by":"publisher","DOI":"10.1038\/359295a0"},{"key":"2016061019141304000_23.5.445.17","first-page":"245","article-title":"The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells","volume":"3","author":"Levine","year":"1996","journal-title":"Perspectives on Developmental Neurobiology"},{"key":"2016061019141304000_23.5.445.18","first-page":"479","article-title":"Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization","volume":"137","author":"Lloyd","year":"1990","journal-title":"American Journal of Pathology"},{"key":"2016061019141304000_23.5.445.19","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31829723e7"},{"key":"2016061019141304000_23.5.445.20","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.151"},{"key":"2016061019141304000_23.5.445.21","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-015-9398-z"},{"key":"2016061019141304000_23.5.445.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.9.3397"},{"key":"2016061019141304000_23.5.445.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-7431(03)00033-2"},{"key":"2016061019141304000_23.5.445.24","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200208000-00010"},{"key":"2016061019141304000_23.5.445.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001993"},{"key":"2016061019141304000_23.5.445.26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/ATVBAHA.115.306074","article-title":"NG2 ablation reduces low-density lipoprotein retention of synthetic smooth muscle cells and atherogenesis","volume":"36","author":"She","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2016061019141304000_23.5.445.27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0889-8529(18)30472-9","article-title":"Gonadotroph cell pituitary adenomas","volume":"16","author":"Snyder","year":"1987","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"2016061019141304000_23.5.445.28","doi-asserted-by":"publisher","DOI":"10.1007\/BF01600224"},{"key":"2016061019141304000_23.5.445.29","doi-asserted-by":"crossref","unstructured":"Tateno T Asa SL Zheng L Mayr T Ullrich A Ezzat S 2011 The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis. PLoS Genetics 7 e1002400. (doi:10.1371\/journal.pgen.1002400)","DOI":"10.1371\/journal.pgen.1002400"},{"key":"2016061019141304000_23.5.445.30","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0144"},{"key":"2016061019141304000_23.5.445.31","doi-asserted-by":"crossref","unstructured":"Wang J Svendsen A Kmiecik J Immervoll H Skaftnesmo KO Planaguma J Reed RK Bjerkvig R Miletic H Enger PO , . 2011 Targeting the NG2\/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS ONE 6 e23062. (doi:10.1371\/journal.pone.0023062)","DOI":"10.1371\/journal.pone.0023062"},{"key":"2016061019141304000_23.5.445.32","doi-asserted-by":"publisher","DOI":"10.1262\/jrd.2014-031"},{"key":"2016061019141304000_23.5.445.33","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-006-9316-9"},{"key":"2016061019141304000_23.5.445.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-013-9378-1"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/23\/5\/445.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/23\/5\/445.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:53:30Z","timestamp":1784555610000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/23\/5\/445-456\/34100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":34,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1530\/erc-16-0013","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}